These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Effects of diltiazem hydrochloride on serum lipids: comparison with beta-blockers.
    Author: Wada S, Nakayama M, Masaki K.
    Journal: Clin Ther; 1982; 5(2):163-73. PubMed ID: 6130841.
    Abstract:
    The effects of diltiazem hydrochloride, a vasodilator often used to treat hypertension, and beta-blockers (pindolol and propranolol hydrochloride) on lipid metabolism and carbohydrate metabolism were assessed by measuring serum levels of total cholesterol, high-density-lipoproteins (HDL)-cholesterol, triglycerides, and glucose in patients taking these drugs for three months. No significant changes were observed in any of the values in patients taking either diltiazem hydrochloride (180 mg/day) or beta-blockers (15 mg of pindolol or 60 mg of propranolol daily). The decrease in HDL-cholesterol levels and increase in triglyceride levels reported in 1978 to be associated with use of propranolol, and with the concomitant use of hydrochlorothiazide and propranolol, was not found.
    [Abstract] [Full Text] [Related] [New Search]